Fourth Department of Internal Medicine and Hematology, Faculty of MedicineUniversity Hospital of Hradec KrálovéHradec Králové, Kralovehradecky kraj, Czech Republic
OC 65.1 - Long-Term Efficacy and Safety With Oral Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients With Immune Thrombocytopenia
Tuesday, June 27, 202314:45 – 15:00 ET
